| The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients M Bieniasz, K Oszajca, M Eusebio, J Kordiak, J Bartkowiak, J Szemraj Lung cancer 66 (3), 319-326, 2009 | 84 | 2009 |
| Short-form Ron promotes spontaneous breast cancer metastasis through interaction with phosphoinositide 3-kinase X Liu, L Zhao, YS DeRose, YC Lin, M Bieniasz, H Eyob, SS Buys, ... Genes & cancer 2 (7), 753-762, 2011 | 55 | 2011 |
| The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis AL Drumond-Bock, M Bieniasz Molecular Cancer 20 (1), 145, 2021 | 45 | 2021 |
| Preclinical efficacy of Ron kinase inhibitors alone and in combination with PI3K inhibitors for treatment of sfRon-expressing breast cancer patient-derived xenografts M Bieniasz, P Radhakrishnan, N Faham, JP De La O, AL Welm Clinical Cancer Research 21 (24), 5588-5600, 2015 | 40 | 2015 |
| Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome MN Hossen, L Wang, HR Chinthalapally, JD Robertson, KM Fung, ... Science advances 6 (30), eaba5379, 2020 | 39 | 2020 |
| Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer S Elayapillai, S Ramraj, DM Benbrook, M Bieniasz, L Wang, G Pathuri, ... Gynecologic oncology 160 (1), 302-311, 2021 | 31 | 2021 |
| Short-form Ron is a novel determinant of ovarian cancer initiation and progression KM Moxley, L Wang, AL Welm, M Bieniasz Genes & cancer 7 (5-6), 169, 2016 | 21 | 2016 |
| Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: Pre-clinical updates M Cybula, M Bieniasz Oncotarget 13, 553, 2022 | 12 | 2022 |
| Upregulation of Succinate Dehydrogenase (SDHA) Contributes to Enhanced Bioenergetics of Ovarian Cancer Cells and Higher Sensitivity to Anti-Metabolic Agent Shikonin L Wang, M Cybula, M Rostworowska, L Wang, P Mucha, M Bulicz, ... Cancers 14 (20), 5097, 2022 | 10 | 2022 |
| Gold nanoparticles disrupt the IGFBP2/mTOR/PTEN axis to inhibit ovarian cancer growth MN Hossen, L Wang, SKD Dwivedi, Y Zhang, G Rao, CK Elechalwar, ... Advanced Science 9 (31), 2200491, 2022 | 8 | 2022 |
